Rallybio Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RLYB Nasdaq 2836 www.rallybio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rallybio Corporation

Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting - Sep 30th, 2024 12:00 pm
Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Meeting - Sep 23rd, 2024 12:00 pm
Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit - Sep 10th, 2024 12:00 pm
Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree - Sep 9th, 2024 9:15 pm
Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis - Aug 29th, 2024 12:00 pm
Rallybio to Present at Upcoming Investor Conferences - Aug 27th, 2024 12:00 pm
Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock? - Aug 14th, 2024 4:00 pm
Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth? - Aug 10th, 2024 2:28 pm
Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates - Aug 8th, 2024 12:00 pm
Rallybio to Present at the 2024 Jones Healthcare Seaside Summit - Jul 9th, 2024 12:00 pm
Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations - Jun 17th, 2024 12:00 pm
3 Sorry Biotech Stocks to Sell in May While You Still Can - May 31st, 2024 11:00 am
3 Biotech Stocks to Sell in May Before They Crash & Burn - May 10th, 2024 10:30 am
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates - May 9th, 2024 12:00 pm
Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference - May 7th, 2024 12:00 pm
FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting - Apr 17th, 2024 8:01 pm
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up - Apr 12th, 2024 2:23 pm
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) - Apr 10th, 2024 8:01 pm
J&J, Rallybio partner on drug development for rare fetal condition - Apr 10th, 2024 5:01 pm
Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting - Apr 1st, 2024 2:05 pm